These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30016491)

  • 1. Implementing a dengue vaccination programme-who, where and how?
    E Clapham H; A Wills B
    Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):367-368. PubMed ID: 30016491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projected costs associated with school-based screening to inform deployment of Dengvaxia: Vietnam as a case study.
    Turner HC; Wills BA; Rahman M; Quoc Cuong H; Thwaites GE; Boni MF; Clapham HE
    Trans R Soc Trop Med Hyg; 2018 Aug; 112(8):369-377. PubMed ID: 29982700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
    Lee JS; Lourenço J; Gupta S; Farlow A
    Vaccine; 2018 Apr; 36(17):2346-2355. PubMed ID: 29573874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Path to a Dengue Vaccine: Learning from Human Natural Dengue Infection Studies and Vaccine Trials.
    de Silva AM; Harris E
    Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 28716891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADE and dengue vaccination.
    Martínez-Vega RA; Carrasquila G; Luna E; Ramos-Castañeda J
    Vaccine; 2017 Jul; 35(32):3910-3912. PubMed ID: 28623027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for a dengue virus vaccine.
    Whitehead SS; Blaney JE; Durbin AP; Murphy BR
    Nat Rev Microbiol; 2007 Jul; 5(7):518-28. PubMed ID: 17558424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue: Status of current and under-development vaccines.
    Redoni M; Yacoub S; Rivino L; Giacobbe DR; Luzzati R; Di Bella S
    Rev Med Virol; 2020 Jul; 30(4):e2101. PubMed ID: 32101634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination? The Risks of Incomplete Immunity to Dengue Virus Revealed by Vaccination.
    Whitehead SS; Subbarao K
    Cold Spring Harb Perspect Biol; 2018 Jun; 10(6):. PubMed ID: 28716894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Optimal Age of Vaccination Against Dengue with an Age-Dependent Biting Rate with Application to Brazil.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Bull Math Biol; 2020 Jan; 82(1):12. PubMed ID: 31933012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dengue vaccine: WHO position paper, September 2018 - Recommendations.
    Vaccine; 2019 Aug; 37(35):4848-4849. PubMed ID: 30424888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing dengue vaccine development.
    Feinberg MB; Ahmed R
    Science; 2017 Nov; 358(6365):865-866. PubMed ID: 29146795
    [No Abstract]   [Full Text] [Related]  

  • 12. Optimal dengue vaccination strategies of seropositive individuals.
    Shim E
    Math Biosci Eng; 2019 Feb; 16(3):1171-1189. PubMed ID: 30947414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccines licensed and in clinical trials for the prevention of dengue.
    Torresi J; Ebert G; Pellegrini M
    Hum Vaccin Immunother; 2017 May; 13(5):1059-1072. PubMed ID: 28281864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
    Valdés I; Lazo L; Hermida L; Guillén G; Gil L
    Front Immunol; 2019; 10():1956. PubMed ID: 31507591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal age of vaccination against dengue in Brazil based on serotype-specific forces of infection derived from serological data.
    Maier SB; Massad E; Amaku M; Burattini MN; Greenhalgh D
    Math Med Biol; 2021 Mar; 38(1):1-27. PubMed ID: 32671383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue infection and advances in dengue vaccines for children.
    Halstead SB; Dans LF
    Lancet Child Adolesc Health; 2019 Oct; 3(10):734-741. PubMed ID: 31378686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD4
    Angelo MA; Grifoni A; O'Rourke PH; Sidney J; Paul S; Peters B; de Silva AD; Phillips E; Mallal S; Diehl SA; Kirkpatrick BD; Whitehead SS; Durbin AP; Sette A; Weiskopf D
    J Virol; 2017 Mar; 91(5):. PubMed ID: 27974563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
    Lam SK; Burke D; Capeding MR; Chong CK; Coudeville L; Farrar J; Gubler D; Hadinegoro SR; Hanna J; Lang J; Lee HL; Leo YS; Luong CQ; Mahoney R; McBride J; Mendez-Galvan J; Ng LC; Nimmannitya S; Ooi EE; Shepard D; Smit J; Teyssou R; Thomas L; Torresi J; Vasconcelos P; Wirawan DN; Yoksan S
    Vaccine; 2011 Nov; 29(51):9417-22. PubMed ID: 21864627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and immunization strategies for dengue prevention.
    Liu Y; Liu J; Cheng G
    Emerg Microbes Infect; 2016 Jul; 5(7):e77. PubMed ID: 27436365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries.
    Aguiar M; Stollenwerk N; Halstead SB
    PLoS Negl Trop Dis; 2016 Dec; 10(12):e0005179. PubMed ID: 28002420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.